戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion (eg, undifferentiated bilateral chronic anterior uveitis).
2 ated with an increased risk of noninfectious anterior uveitis.
3 hanged after exclusion of eyes with herpetic anterior uveitis.
4 n between vitamin D levels and noninfectious anterior uveitis.
5 ng the iris region of the uveal tract during anterior uveitis.
6 n patients (41%) were diagnosed with chronic anterior uveitis.
7 tcome and Measure: Presence of noninfectious anterior uveitis.
8 k factors for elevated IOP were male sex and anterior uveitis.
9 ated with an increased risk of noninfectious anterior uveitis.
10 hanges in patients with suspected infectious anterior uveitis.
11 tis and 1 had psoriatic arthritis-associated anterior uveitis.
12 rial enrolled 5 patients with chronic active anterior uveitis.
13 ble tool for the diagnosis and management of anterior uveitis.
14 active inflammation in patients with chronic anterior uveitis.
15 n between vitamin D levels and noninfectious anterior uveitis.
16 aqueous humor during allograft rejection and anterior uveitis.
17   The EAAU model replicates idiopathic human anterior uveitis.
18 erves as an animal model of human idiopathic anterior uveitis.
19 = 0.0001) and resulted in the development of anterior uveitis.
20 tis (EIU) is a model that mimics human acute anterior uveitis.
21  may be a new therapeutic strategy for acute anterior uveitis.
22 raocular injection of zymosan induced severe anterior uveitis.
23 erage BCVA remained stable for patients with anterior uveitis (20/30 at baseline to 20/33 at 10 years
24 cluding decrease in vision (15.8% vs. 2.3%), anterior uveitis (26.4% vs. 16.5%), peripheral ulcerativ
25 ow-up, 286 (31.3%) were classified as having anterior uveitis, 303 (33.3%) as intermediate uveitis, a
26 of 7 patients had bilateral nongranulomatous anterior uveitis: 4 with chronic and 1 with recurrent di
27  among eyes with panuveitis (77.1%), chronic anterior uveitis (48.3%), and intermediate uveitis (48.0
28  Nomenclature anatomic subtype was 28.1% for anterior uveitis, 57.0% for intermediate uveitis, and 43
29   Concurrent anterior segment signs included anterior uveitis (80.0%) and anterior scleritis (20.0%).
30  week of onset of her first episode of acute anterior uveitis, a 45 year-old Caucasian lady developed
31  delineate the role played by MCP-1 in acute anterior uveitis, a common ocular inflammation, MCP-1(-/
32                                        Acute anterior uveitis (AAU) affects approximately 40% of pati
33 al painful red eye were diagnosed with acute anterior uveitis (AAU) after examination by an ophthalmo
34 mmune privilege, (auto)immune-mediated acute anterior uveitis (AAU) is relatively common.
35                      Patients diagnosed with anterior uveitis (active or inactive) and controls.
36 d 2 male patients; 4 patients had idiopathic anterior uveitis and 1 had psoriatic arthritis-associate
37      One hundred patients with noninfectious anterior uveitis and 100 patients without uveitis were r
38 ions and investigated for the development of anterior uveitis and an immune response to the purified
39  observations may extend to idiopathic human anterior uveitis and facilitate the development of antig
40                                              Anterior uveitis and hypotony have not returned with six
41 o MS accumulation preceded clinical signs of anterior uveitis and leukocyte adhesion in iris vasculat
42 port a case of a man who developed bilateral anterior uveitis and macular serous retinal detachment d
43 efflux in inflammatory eye diseases, such as anterior uveitis and retinochoroiditis.
44   Lewis rats sensitized to rat MAA developed anterior uveitis, and EAAU induced by rat MAA can be ado
45 ction, leukostasis, retinal damage, signs of anterior uveitis, and uncoupling of nitric oxide synthas
46 tive uveitis (HR, 1.3; 95% CI, 1.1-1.5), and anterior uveitis as opposed to intermediate (HR, 1.2), p
47 s is the second clinical report of bilateral anterior uveitis associated with macular serous retinal
48 ing the iris/ciliary body of Lewis rats with anterior uveitis (AU) that had been induced by myelin ba
49 ure (IOP) and secondary glaucoma in herpetic anterior uveitis (AU), owing to either herpes simplex or
50 mmune encephalomyelitis (EAE) and associated anterior uveitis (AU), which recurs.
51 cognized macular edema has been described in anterior uveitis (AU).
52 kin-6 (IL-6) has been strongly implicated in anterior uveitis based on its presence in aqueous humor
53 to the development of therapy for idiopathic anterior uveitis based on selective blockade of the alte
54  depletion by CVF prevented the induction of anterior uveitis by anti-Crry mAb.
55                      Experimental autoimmune anterior uveitis can be induced in Lewis rats by immuniz
56 lower incidence of remission among new-onset anterior uveitis cases included diagnosis with JIA, Behc
57                                              Anterior uveitis, cataract, vitritis, cystoid macular ed
58 1) in an attempt to develop antibody induced anterior uveitis; control animals received 5 microl of s
59                                              Anterior uveitis describes inflammation that involves th
60                                       Severe anterior uveitis developed in Lewis rats injected with a
61                                              Anterior uveitis developed in response to PG immunizatio
62 es of posterior scleritis include concurrent anterior uveitis, disc swelling, and retinal striae.
63  more at risk of vision loss if they had non-anterior uveitis disease, vitreous opacities, retinal de
64 ty was explored in a experimental autoimmune anterior uveitis (EAAU) animal model.
65  initiated to induce experimental autoimmune anterior uveitis (EAAU) in Lewis rats by melanin-associa
66                      Experimental autoimmune anterior uveitis (EAAU) is an organ-specific autoimmune
67                      Experimental autoimmune anterior uveitis (EAAU) serves as an animal model for hu
68                      Experimental autoimmune anterior uveitis (EAAU) serves as an animal model of hum
69 for the induction of experimental autoimmune anterior uveitis (EAAU).
70 y proteins (CRPs) in experimental autoimmune anterior uveitis (EAAU).
71 for the induction of experimental autoimmune anterior uveitis (EAAU).
72 ontophoresis) in patients with noninfectious anterior uveitis; evaluate systemic drug exposures.
73                    A subset of patients with anterior uveitis express the marker, perinuclear anti-ne
74                               Although human anterior uveitis has been historically characterized as
75 itis (HR, 2.21; 95% CI, 1.07-4.55; P = .03), anterior uveitis (HR, 2.68; 95% CI, 1.32-2.35; P = .006)
76 hundred twenty-five patients with idiopathic anterior uveitis (IAU) and 56 with idiopathic intermedia
77 warranted to determine whether long-standing anterior uveitis increases risk of endothelial dysfuncti
78                              With respect to anterior uveitis, intermediate uveitis (aHR, 0.17; 95% C
79                                Compared with anterior uveitis, intermediate uveitis (aHR, 3.1; 95% CI
80                                              Anterior uveitis is among the most common manifestations
81     However, eye involvement is uncommon and anterior uveitis is the only reported ocular adverse man
82 topical corticosteroids as local therapy for anterior uveitis is well-established, but periocular inj
83                                              Anterior uveitis may be part of a systemic illness such
84 athy may present acutely in idiopathic acute anterior uveitis, may be slow to respond to treatment an
85            Most patients were diagnosed with anterior uveitis (n = 1013; 80.7% of ocular inflammation
86 ritis, scleral inflammation of more than 2+, anterior uveitis, ocular hypertension, and associated in
87                               They developed anterior uveitis only if the CI-alpha2 chain underwent p
88 re than 2+ (range, 0-4+; OR, 3.60; P<0.001), anterior uveitis (OR, 1.78; P = 0.033), ocular hypertens
89 nce of inflammatory back pain in a cohort of anterior uveitis patients was found to be 46.8%.
90 of 53 (28%) acute and 35 of 53 (65%) chronic anterior uveitis patients.
91 ker antibody present in 12% of patients with anterior uveitis, recognizes cytoplasmic antigens in the
92 partially explain why, for example, in acute anterior uveitis, the inflammatory disease is often more
93 d inflammation ranged from mild or low-grade anterior uveitis to severe explosive panuveitis complica
94                                     Isolated anterior uveitis, vitritis, and choroidal mass are descr
95     The vitreoretinal manifestations include anterior uveitis, vitritis, pars planitis, focal retinal
96 ne polymorphism with susceptibility to acute anterior uveitis was found in a Mexican population of pa
97                                              Anterior uveitis was the most common location and accoun
98                                Patients with anterior uveitis were recruited from the clinic of an op
99     Fifty-three patients with a diagnosis of anterior uveitis who underwent anterior chamber paracent
100 ing with severe, bilateral, idiopathic acute anterior uveitis with acute hypotony and hypotony maculo
101         Here, we review recent insights into anterior uveitis with regard to clinical presentation, i
102 (687 patients) had a first-ever diagnosis of anterior uveitis within 90 days before initial presentat
103 se in whom this treatment fails and who have anterior uveitis without any retinal lesions and exhibit

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top